The Gorter Model

The goal of the treatment is to improve the immune system (“immune restoration”). The basic elements of the Gorter Model are the integration of the therapies and protocols in a schedule designed specifically for each patient. For more than a decade now, documentation and evaluation of all data is being conducted by research fellows who will receive their masters degree or PhD from German or international universities world-wide through work in association with the Gorter Model team.

Over the past twelve years, more than 4000 patients were treated according to the Gorter Model. Conditions that have been successfully treated include all metastasized solid tumors, such as breast, prostate, lung, brain, liver, colon and bone cancer.

96% of all patients were at the end stages of cancer and for them, the team was their last hope. However, they frequently experience partial remission and stabilize for several years with a very positive quality of life or even sustained and complete remission. The treatment implies hope, although not all patients improve.

The Gorter Model is designed to restore and enhance immune function, enabling the immune system to aggressively and effectively combat cancer cells throughout the body. The treatment may involve some or all of the following therapies to optimize immune function or to directly destroy the cancer cells:

This nontoxic cancer therapy does not debilitate patients. Even patients with Stage IV cancer often report that they feel a certain sense of vitality and are able to maintain or improve their quality of life throughout much of the course of their illness. Conditions that have been successfully treated with the Gorter Model include almost all metastasized solid tumors, such as breast, prostate, lung, brain, liver, colon and bone cancer.

In conclusion, one can say that the Gorter Model is innovative, as it integrates traditional western academic medicine with novel therapies, paying significant attention to all the needs of the patient, and the characteristics of the tumour itself.

In addition, all of these therapies have a sound scientific basis and sufficient clinical experience has been collected to guarantee little to no side effects and a well-founded hope for a good response to therapy.

For the same reason that the behaviour of wildlife in captivity may tell one more about captivity than about wildlife, it is difficult to test anti-cancer drugs in a petri dish. To get a better sense of a cancer’s real vulnerabilities, one need to have the cells grow as a tumour in an animal, or even better, in a human. The same holds true for the functioning of the immune system. One can take blood samples and count, for instance, numbers and percentages of T-lymphocytes, and correlate numbers with function.

But to study the function of T-lymphocytes, researcher should observe the T-lymphocyte directly when it unfolds its immunocompetent function in the tissue of the organs in situ. Therefore, in the Gorter Model, not only immunocompetent cells are counted and identified through surface markers, but also function tests are conducted to document cell function and possible improvement of function during and after therapy. Other treatment modalities will target life style changes. Attention is paid to nutrition, and supplementation with vitamins, antioxidants, and trace elements. Other life style changes might include increased physical activities, like bicycling, swimming and walking (jogging), and exercise under guidance of an instructor. Also, improvement of mental and social functioning is encouraged, and advice and counseling are offered.